Temozolomide Capsule
Product Images NDC 70301-2011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure)

Figure (Figure)
Kaplan-Meier curves depicting overall survival (%) over time in months for patients with newly diagnosed glioblastoma in study MK-7365-051. The chart compares two treatment arms: RT + Temozolomide (TMZ) showing higher survival rates, and RT only, with survival decreasing more rapidly. Numbers at risk are provided below the X-axis for both treatment arms across time points.*
FDA Label Image

Label21 (Label21)

Label21 (Label21)
Packaging label for Temozolomide Capsules, USP 250 mg for oral administration. The label shows storage instructions at 25°C with permitted excursions, warnings about the hazardous nature of the drug, and that the package contains 5 individual sachets each with one capsule. Distributed by OPKO Pharmaceuticals, LLC, Miami, FL. Multiple barcodes and the NDC 70301-2011 are visible.*
FDA Label Image

Label22 (Label22)

Label22 (Label22)
Packaging label for Temozolomide Capsule USP 250 mg by OPKO Pharmaceuticals, LLC. The label includes the product name, strength, dosage form, distributor information, and a warning that the drug is hazardous with instructions to read accompanying directions carefully. A barcode and placeholders for lot and expiration dates are also visible.*
FDA Label Image

Chemical Structure (Temo Structure)

Chemical Structure (Temo Structure)
Chemical structure diagram of the active ingredient temozolomide, showing its molecular ring system with labeled functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.